What questions should I ask my oncologist about metastatic Ovarian Cancer

Key Questions to Ask Your Oncologist About Metastatic Ovarian Cancer

I'm glad you're preparing for your conversation with your oncologist. Asking informed questions helps you understand your situation and participate in treatment decisions. Here are important areas to explore:

UNDERSTANDING YOUR DIAGNOSIS & STAGING

1. Tumor Characteristics & Biomarkers

• "What type of ovarian cancer do I have?" (epithelial, germ cell, stromal, etc.)
• "What is the grade and stage of my cancer, and what does that mean for my prognosis?"
• "Has my tumor been tested for specific biomarkers?" including:
  • BRCA mutations (germline and somatic) - these are particularly important for ovarian cancer and can guide treatment options
  • HRD status (homologous recombination deficiency)
  • MSI/MMR status (microsatellite instability/mismatch repair)
  • PD-L1 expression (for immunotherapy eligibility)
  • TP53, KRAS, or other mutations

2. About Your Specific Test Results

• "Can you explain what each biomarker means for my treatment options?"
• "If I haven't had comprehensive genomic testing, should I get it? What would it show?"
• "What is my CA-125 level, and what does it tell us about my disease?"

---

TREATMENT PLANNING

3. First-Line Treatment Strategy

• "What is the standard treatment plan you're recommending, and why?"
• "Will I receive chemotherapy, targeted therapy, immunotherapy, or a combination?"
• "If chemotherapy is recommended, what drugs and what schedule?"
• "Are there clinical trials I should consider for my specific biomarker profile?"

4. Targeted & Precision Therapies According to recent medical literature on ovarian cancer treatment, ask:

• "Based on my BRCA status, am I eligible for PARP inhibitors?" (These drugs like olaparib target BRCA mutations)
• "What about bevacizumab (Avastin) - is this appropriate for my case?"
• "Are there other targeted drugs based on my specific mutations?"
• "What is the evidence that these drugs will work for my particular cancer?"

5. Immunotherapy Options

• "Am I a candidate for immunotherapy? Why or why not?"
• "What immunotherapy drugs are being considered?"
• "How would immunotherapy be combined with chemotherapy or other treatments?"

---

TREATMENT SIDE EFFECTS & MANAGEMENT

6. Expected Side Effects

• "What are the most common side effects I should expect?"
• "Which side effects are serious and require immediate medical attention?"
• "How will we manage side effects?" (nausea, fatigue, neuropathy, etc.)
• "Are there supportive care options available?"

7. Quality of Life

• "How will treatment affect my daily activities, work, and energy levels?"
• "What physical activities are safe during treatment?"
• "Are there nutritional recommendations or restrictions?"

---

MONITORING & FOLLOW-UP

8. How We'll Track Your Response

• "How will we monitor whether the treatment is working?"
• "What imaging or blood tests will we use?" (CT scans, CA-125 levels, etc.)
• "How often will we reassess my response?"
• "What would indicate the treatment needs to change?"

9. About Liquid Biopsies & Advanced Monitoring

• "Are there blood-based tests (liquid biopsies) that could help monitor my disease?"
• "Could circulating tumor DNA (ctDNA) testing help track my response?"

---

TREATMENT DURATION & NEXT STEPS

10. Timeline & Expectations

• "How long will this treatment plan last?"
• "What happens after the initial treatment phase?"
• "If the cancer progresses, what are second-line options?"
• "Are there maintenance therapies I should know about?"

11. Clinical Trials

• "Are there clinical trials appropriate for my specific biomarker profile?"
• "How do I find trials, and what would participation involve?"
• "What are the potential benefits and risks of trial participation?"

---

IMPORTANT CONTEXT FOR YOUR QUESTIONS

Why Biomarkers Matter for Ovarian Cancer: According to medical literature on precision oncology, ovarian cancer treatment is increasingly personalized based on tumor characteristics. For example:

• BRCA mutations (found in about 15-20% of ovarian cancers) often respond well to PARP inhibitors
• HRD status helps predict response to platinum-based chemotherapy and PARP inhibitors
• Specific mutations may open access to targeted therapies

Molecular Testing Approach: As discussed in precision medicine webinars, comprehensive testing that looks at multiple aspects of your tumor (genomics, transcriptomics, and sometimes proteomics) can provide the most complete picture for treatment planning.

---

QUESTIONS ABOUT YOUR CARE TEAM & DECISION-MAKING

12. Coordination & Expertise

• "Do you recommend a multidisciplinary team approach?" (oncology, surgery, pathology)
• "Should I see a gynecologic oncologist specifically?"
• "Will my care be coordinated across different specialists?"

13. Second Opinions

• "Would you support me getting a second opinion on my diagnosis or treatment plan?"
• "Are there specialized cancer centers you'd recommend for consultation?"

---

PREPARING FOR YOUR APPOINTMENT

Before you meet with your oncologist:

• Bring all pathology reports and imaging results
• Write down your questions in order of priority
• Bring someone to take notes or record the conversation (with permission)
• Ask for written summaries of the treatment plan
• Request copies of all test results and reports

After your appointment:

• Ask for contact information for questions that arise
• Clarify the next steps and timeline
• Confirm when you'll start treatment
• Ask about support resources (social work, nutrition, support groups)

---

ADDITIONAL RESOURCES

According to the American Cancer Society and NCCN (National Comprehensive Cancer Network) Guidelines for ovarian cancer, patients benefit from:

• Genetic counseling if BRCA testing is recommended
• Participation in support groups
• Access to patient education materials
• Coordination with advocacy organizations focused on ovarian cancer

Organizations like the Ovarian Cancer Research Alliance and similar advocacy groups can provide additional educational materials and support.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.